Please use this identifier to cite or link to this item:
Title: Association of Changes in Bone Remodeling and Coronary Calcification in Hemodialysis Patients: A Prospective Study
Authors: Barreto, Daniela Veit [UNIFESP]
Barreto, Fellype de Carvalho [UNIFESP]
Carvalho, Aluizio Barbosa de [UNIFESP]
Cuppari, Lilian [UNIFESP]
Draibe, Sergio Antonio [UNIFESP]
Dalboni, Maria Aparecida [UNIFESP]
Affonso Moyses, Rosa Maria [UNIFESP]
Neves, Katia Rodrigues [UNIFESP]
Jorgetti, Vanda [UNIFESP]
Miname, Marcio
Santos, Raul D.
Canziani, Maria Eugenia F. [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
Universidade de São Paulo (USP)
Keywords: Hemodialysis
renal osteodystrophy
vascular calcification
cardiovascular disease
Issue Date: 1-Dec-2008
Publisher: Elsevier B.V.
Citation: American Journal of Kidney Diseases. Philadelphia: W B Saunders Co-Elsevier Inc, v. 52, n. 6, p. 1139-1150, 2008.
Abstract: Background: Vascular calcification is common and constitutes a prognostic marker of mortality in the hemodialysis population. Derangements of mineral metabolism may influence its development. the aim of this study is to prospectively evaluate the association between bone remodeling disorders and progression of coronary artery calcification (CAC) in hemodialysis patients.Study Design: Cohort study nested within a randomized controlled trial.Setting & Participants: 64 stable hemodialysis patients.Predictor: Bone-related laboratory parameters and bone histomorphometric characteristics at baseline and after 1 year of follow-up.Outcomes: Progression of CAC assessed by means of coronary multislice tomography at baseline and after 1 year of follow-up. Baseline calcification score of 30 Agatston units or greater was defined as calcification. Change in calcification score of 15% or greater was defined as progression.Results: of 64 patients, 26 (40%) had CAC at baseline and 38 (60%) did not. Participants without CAC at baseline were younger (P < 0.001), mainly men (P = 0.03) and nonwhite (P = 0.003), and had lower serum osteoprotegerin levels (P = 0.003) and higher trabecular bone volume (P = 0.001). Age (P 0.003; beta coefficient = 1.107; 95% confidence interval [Cl], 1.036 to 1.183) and trabecular bone volume (P = 0.006; beta coefficient = 0.828; 95% Cl, 0.723 to 0.948) were predictors for CAC development. of 38 participants who had calcification at baseline, 26 (68%) had CAC progression in 1 year. Progressors had lower bone-specific alkaline phosphatase (P = 0.03) and deoxypyridinoline levels (P = 0.02) on follow-up, and low turnover was mainly diagnosed at the 12-month bone biopsy (P = 0.04). Low-turnover bone status at the 12-month bone biopsy was the only independent predictor for CAC progression (P = 0.04; beta coefficient = 4.5; 95% Cl, 1.04 to 19.39). According to bone histological examination, nonprogressors with initially high turnover (n = 5) subsequently had decreased bone formation rate (P = 0.03), and those initially with low turnover (n = 7) subsequently had increased bone formation rate (P = 0.003) and osteoid volume (P = 0.001).Limitations: Relatively small population, absence of patients with severe hyperparathyroidism, short observational period.Conclusions: Lower trabecular bone volume was associated with CAC development, whereas improvement in bone turnover was associated with lower CAC progression in patients with high- and low-turnover bone disorders. Because CAC is implicated in cardiovascular mortality, bone derangements may constitute a modifiable mortality risk factor in hemodialysis patients.
ISSN: 0272-6386
Other Identifiers:
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.